Wird geladen...
Circular HER2 RNA positive triple negative breast cancer is sensitive to Pertuzumab
BACKGROUND: Triple negative breast cancer (TNBC) remains the most challenging breast cancer subtype so far. Specific therapeutic approaches have rarely achieved clinical improvements in treatment of TNBC patients and effective molecular biomarkers are largely unknown. METHODS: We used paired TNBC sa...
Gespeichert in:
| Veröffentlicht in: | Mol Cancer |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BioMed Central
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7488427/ https://ncbi.nlm.nih.gov/pubmed/32917240 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12943-020-01259-6 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|